title: Effects of prophylactic administration of bacteriophages to immunosuppressed mice infected with Staphylococcus aureus.
abstract: BACKGROUND
  Bacteriophages can be successfully applied to treat infections caused by antibiotic-resistant bacteria. Until now no attempts have been undertaken to treat infections in immunosuppressed patients with phages. In this work we investigated the prophylactic efficacy of specific bacteriophages in CBA mice treated with cyclophosphamide (CP) and infected with Staphylococcus aureus.
  
  
  RESULTS
  High numbers of bacterial colony-forming units in the organs as well as elevated tumor necrosis factor and interleukin-6 serum concentrations in CP-treated and S. aureus-infected mice were significantly lowered upon application of phages. The phages markedly increased the percentage of circulating neutrophils and immature cells from the myelocytic and lymphocytic lineages in CP-treated, S. aureus-infected mice as well as of myelocytes and immature neutrophils in the bone marrow. In addition, phages stimulated in such mice generation of specific agglutinins against S. aureus.
  
  
  CONCLUSIONS
  Application of specific phages to immunosuppressed mice prior to infection with S. aureus proved very effective, suggesting a potential benefit of phage therapy in immunocompromised patients experiencing bacterial infections.
authors.affiliation: Institute of Immunology and Experimental Therapy, Polish Academy of Science, Wrocław, Poland. zimecki@iitd.pan.wroc.pl
authors.forename: Michał
authors.initials: M
authors.lastname: Zimecki
authors.forename: Jolanta
authors.initials: J
authors.lastname: Artym
authors.forename: Maja
authors.initials: M
authors.lastname: Kocieba
authors.forename: Beata
authors.initials: B
authors.lastname: Weber-Dabrowska
authors.forename: Jan
authors.initials: J
authors.lastname: Borysowski
authors.forename: Andrzej
authors.initials: A
authors.lastname: Górski
mesh_terms: D000818:Animals; D000907:Antibodies, Bacterial / Q000097:blood; D003520:Cyclophosphamide / Q000494:pharmacology; D004195:Disease Models, Animal; D042381:Granulocyte Precursor Cells / Q000276:immunology; D016867:Immunocompromised Host; D007166:Immunosuppressive Agents / Q000494:pharmacology; D015850:Interleukin-6 / Q000097:blood / Q000276:immunology; D008297:Male; D051379:Mice; D008808:Mice, Inbred CBA; D009504:Neutrophils / Q000276:immunology; D013203:Staphylococcal Infections / Q000276:immunology / Q000382:microbiology / Q000628:therapy*; D013204:Staphylococcus Phages; D013211:Staphylococcus aureus / Q000821:virology*; D014409:Tumor Necrosis Factor-alpha / Q000097:blood / Q000276:immunology
chemical_list: D000907:Antibodies, Bacterial; D007166:Immunosuppressive Agents; D015850:Interleukin-6; D014409:Tumor Necrosis Factor-alpha; D003520:Cyclophosphamide
references.citation: Can J Comp Med. 1975 Apr;39(2):227-30
references.pmid: 804981
references.citation: Infect Immun. 2009 Jan;77(1):485-91
references.pmid: 19001080
references.citation: Arch Surg. 1984 Feb;119(2):156-60
references.pmid: 6320765
references.citation: Immunol Lett. 2003 Oct 9;89(1):9-15
references.pmid: 12946859
references.citation: Ann Rheum Dis. 1987 Dec;46(12):883-8
references.pmid: 2962540
references.citation: Curr Opin Investig Drugs. 2009 Aug;10(8):766-74
references.pmid: 19649921
references.citation: Pharmacol Rep. 2008 Mar-Apr;60(2):183-9
references.pmid: 18443379
references.citation: J Endotoxin Res. 2003;9(4):225-36
references.pmid: 12935353
references.citation: Arch Immunol Ther Exp (Warsz). 1987;35(5):553-61
references.pmid: 3455646
references.citation: J Antimicrob Chemother. 2000 Aug;46 Suppl A:41-48
references.pmid: 10969051
references.citation: J Leukoc Biol. 2004 Apr;75(4):604-11
references.pmid: 14694182
references.citation: J Immunol. 1996 Sep 15;157(6):2514-20
references.pmid: 8805652
references.citation: East Afr Med J. 2001 Jul;78(7):370-2
references.pmid: 11957262
references.citation: Nat Rev Microbiol. 2004 Feb;2(2):166-73
references.pmid: 15040264
references.citation: Eur J Haematol. 2001 May;66(5):287-96
references.pmid: 11422407
references.citation: Br J Haematol. 2004 Nov;127(3):326-34
references.pmid: 15491295
references.citation: J Infect Dis. 1993 Jan;167(1):240-4
references.pmid: 8418175
references.citation: Virus Res. 2008 Feb;131(2):233-42
references.pmid: 17996972
references.citation: Arch Immunol Ther Exp (Warsz). 2000;48(1):31-7
references.pmid: 10722229
references.citation: Appl Environ Microbiol. 1982 Aug;44(2):466-70
references.pmid: 7125657
references.citation: Arch Surg. 1993 Jan;128(1):73-7; discussion 77-8
references.pmid: 8418784
references.citation: Zh Mikrobiol Epidemiol Immunobiol. 1999 Nov-Dec;(6):63-7
references.pmid: 10876854
references.citation: Mult Scler. 2002 Apr;8(2):142-54
references.pmid: 11990872
references.citation: Med Sci Monit. 2004 Mar;10(3):BR84-9
references.pmid: 14976460
references.citation: J Immunol. 2002 Jan 1;168(1):308-15
references.pmid: 11751975
references.citation: FEMS Immunol Med Microbiol. 2002 Oct 11;34(2):135-8
references.pmid: 12381464
references.citation: Cell Mol Biol Lett. 2003;8(3):699-711
references.pmid: 12949610
references.citation: Rheumatol Int. 1997;17(2):55-60
references.pmid: 9266621
references.citation: Immunobiology. 2003;207(3):197-205
references.pmid: 12777061
references.citation: Infect Immun. 2003 Jul;71(7):3782-6
references.pmid: 12819060
references.citation: Immunopharmacology. 1996 Oct;35(1):71-82
references.pmid: 8913797
references.citation: Ann Rheum Dis. 2002 Oct;61(10):883-8
references.pmid: 12228157
references.citation: Transplant Proc. 2006 Jan-Feb;38(1):331-3
references.pmid: 16504739
references.citation: Anticancer Res. 2004 Nov-Dec;24(6):3991-5
references.pmid: 15736444
references.citation: Infect Immun. 1978 Apr;20(1):58-65
references.pmid: 352938
references.citation: Inflamm Res. 2008 Jul;57(7):340-9
references.pmid: 18607538
references.citation: J Immunol Methods. 1986 Dec 4;95(1):99-105
references.pmid: 3782828
references.citation: Am J Hematol. 2000 Jan;63(1):35-7
references.pmid: 10602166
references.citation: Med Microbiol Immunol. 2006 Sep;195(3):143-50
references.pmid: 16447074
references.citation: Proc Natl Acad Sci U S A. 1986 Dec;83(24):9679-83
references.pmid: 2948184
references.citation: Int J Infect Dis. 2008 Sep;12(5):466-71
references.pmid: 18400541
references.citation: Antimicrob Agents Chemother. 2001 Mar;45(3):649-59
references.pmid: 11181338